PD-1 expression on NK cells can be related to cytokine stimulation and tissue residency

Although PD-1 was shown to be a hallmark of T cells exhaustion, controversial studies have been reported on the role of PD-1 on NK cells. Here, we found by flow cytometry and single cell RNA sequencing analysis that PD-1 can be expressed on MHC class I-deficient tumor-infiltrating NK cells in vivo. We also demonstrate distinct alterations in the phenotype of PD-1-deficient NK cells which in part could be attributed to a decrease in tumor-infiltrating NK cells in PD-1-deficient mice. NK cells from PD-1-deficient mice exhibited a more mature phenotype which might reduce their capacity to migrate and kill in vivo. Finally, our results demonstrate that PD-L1 molecules in membranes of PD-1-deficient NK cells migrate faster than in NK cells from wildtype mice, suggesting that PD-1 and PD-L1 form cis interactions with each other on NK cells.

[1]  N. Tumino,et al.  Glucocorticoids and the cytokines IL-12, IL-15 and IL-18 present in the tumor microenvironment induce PD-1 expression on human Natural Killer cells. , 2020, The Journal of allergy and clinical immunology.

[2]  D. Longo,et al.  Minimal PD-1 expression in mouse and human NK cells under diverse conditions. , 2020, The Journal of clinical investigation.

[3]  R. Negrin,et al.  Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion , 2020, Frontiers in Immunology.

[4]  J. Lee,et al.  Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. , 2019, JAMA oncology.

[5]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[6]  E. Hui,et al.  Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells , 2018, Cell reports.

[7]  S. Endres,et al.  Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies , 2018, Scientific Reports.

[8]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[9]  S. Khakoo,et al.  IL‐12 and IL‐15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells , 2017, Immunity, inflammation and disease.

[10]  M. Colonna,et al.  Expression of CD226 is associated to but not required for NK cell education , 2017, Nature Communications.

[11]  M. Dominguez-Villar,et al.  Sensitivity of dendritic cells to NK‐mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226‐driven interactions , 2016, Journal of leukocyte biology.

[12]  T. Kambayashi,et al.  Cytokines Induce Faster Membrane Diffusion of MHC Class I and the Ly49A Receptor in a Subpopulation of Natural Killer Cells , 2016, Front. Immunol..

[13]  D. Noonan,et al.  A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis , 2014, Journal of the National Cancer Institute.

[14]  Junsang Doh,et al.  Negative role of inducible PD‐1 on survival of activated dendritic cells , 2014, Journal of leukocyte biology.

[15]  E. Plimack,et al.  PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection , 2013, Cancer Immunology Research.

[16]  Åsa K. Björklund,et al.  Smart-seq2 for sensitive full-length transcriptome profiling in single cells , 2013, Nature Methods.

[17]  Adam Coleman,et al.  PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection. , 2012, Viral immunology.

[18]  C. Drake,et al.  Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. , 2012, Current opinion in immunology.

[19]  P. Validire,et al.  Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. , 2011, Cancer research.

[20]  L. Zitvogel,et al.  IL-18 induces PD-1-dependent immunosuppression in cancer. , 2011, Cancer research.

[21]  Baptiste N. Jaeger,et al.  Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance , 2011, Science Signaling.

[22]  V. García,et al.  Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. , 2010, The Journal of infectious diseases.

[23]  G. Gao,et al.  A dimeric structure of PD-L1: functional units or evolutionary relics? , 2010, Protein & Cell.

[24]  G. Zhu,et al.  PD-1 on dendritic cells impedes innate immunity against bacterial infection. , 2009, Blood.

[25]  Sofia Johansson,et al.  The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. , 2009, Blood.

[26]  Liping Yang,et al.  Cytokine-induced memory-like natural killer cells , 2009, Proceedings of the National Academy of Sciences.

[27]  R. Rigler,et al.  Quantitative single-molecule imaging by confocal laser scanning microscopy , 2008, Proceedings of the National Academy of Sciences.

[28]  R. Offringa,et al.  Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination. , 2007, Cancer research.

[29]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[30]  R. Vance,et al.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.

[31]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[32]  M. Caligiuri,et al.  The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector. , 2019, Cancer discovery.

[33]  L. Thomsen,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. , 2004, Nature immunology.